3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma
1
Interventions
pembrolizumab
311
Nivolumab
159
Carboplatin
158
Cisplatin
140
Cyclophosphamide
135
Paclitaxel
129
Magnetic Resonance Spectroscopy
99
Specimen Handling
96
Radiotherapy
93
Gemcitabine
88
Dexamethasone
86
Biopsy
81
Ipilimumab
81
Docetaxel
78
Doxorubicin
77
Rituximab
71
Etoposide
69
durvalumab
62
Lenalidomide
61
Radiation
61
atezolizumab
60
Prednisone
59
Pemetrexed
58
Taxes
58
Bevacizumab
55
fludarabine
54
olaparib
53
Vincristine
52
Cytarabine
51
Fluorouracil
48
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Spiritual Therapies
×
1 year
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts